Study: Statins May Protect the Heart from Chemotherapy Treatment of Early Breast Cancer
January 7th 2021According to the study authors, previous small studies suggested that women taking statins may have less heart muscle damage from these types of chemotherapy, yet the exact mechanisms of how statins protect against the cardiac cell damage remains unknown.
Read More
Communities in Greatest Need of Pharmacy Access Are Identified in Los Angeles County
January 7th 2021A recent study investigated the existence of “pharmacy deserts” in Los Angeles County in relation to the social determinants of health that show which communities have the greatest need for pharmacy access.
Read More
Study: Transfusions With Higher Red Blood Cell Levels Do Not Improve Preterm Baby Outcomes
January 7th 2021The study, which appears in The New England Journal of Medicine, is the largest to-date to compare thresholds for blood transfusions in premature babies, according to the press release.
Read More
FDA Grants Breakthrough Designation to Tiragolumab Plus Atezolizumab for NSCLC
January 7th 2021The FDA has granted a breakthrough therapy designation to tiragolumab for use in combination with atezolizumab (Tecentriq) in the frontline treatment of patients with metastatic non­–small cell lung cancer.
Read More
Potential Source of Chronic Inflammation in Patients With Obesity May Lead to Treatment
January 6th 2021Chronic, low-level inflammation is one of the main causes of the diseases associated with obesity. For this reason, researchers investigated which cell type was responsible for triggering inflammation in fat tissue.
Read More
The Relationship Between Cost Effectiveness, National Vaccination Programs
January 6th 2021A new thesis presented at Sahlgrenska Academy, University of Gothenburg, found that although immunizing children against chicken pox saves money, offering shingles vaccinations to all adults 65 years of age would not.
Read More
CAR T-cell Therapy Application for Large B-cell Lymphoma Remains Under FDA Review
January 5th 2021The biologics license application lisocabtagene maraleucel in adult patients with relapsed/refractory large B-cell lymphoma following at least 2 previous therapies continues to be under regulatory review by the FDA.
Read More
Study: Cancer Researchers Identify Potential New Class of Drugs to Treat Blood, Bone Marrow Cancers
January 4th 2021The research team designed TETi76 to replicate and amplify the effects of a natural molecule called 2-hydroxyglutarate (2HG), which inhibits the enzymatic activity of TET genes.
Read More
Pharmacy Quality Alliance Names New CEO
January 4th 2021PQA is a national quality organization that brings 250 organizations from across health care together to develop and implement quality measures, conduct research and provide education that supports better medication use and high-quality care.
Read More